Alpa Laboratories Limited (NSE:ALPA)
India flag India · Delayed Price · Currency is INR
94.44
+0.03 (0.03%)
Aug 29, 2025, 3:29 PM IST
0.03%
Market Cap1.99B
Revenue (ttm)1.10B
Net Income (ttm)261.75M
Shares Out21.04M
EPS (ttm)12.54
PE Ratio7.53
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,990
Average Volume19,176
Open95.91
Previous Close94.41
Day's Range94.35 - 96.39
52-Week Range90.36 - 144.50
Beta0.64
RSI39.12
Earnings DateAug 12, 2025

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter pharmaceutical products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, creams, gels, and ointments for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and col... [Read more]

Sector Healthcare
Founded 1967
Employees 410
Stock Exchange National Stock Exchange of India
Ticker Symbol ALPA
Full Company Profile

Financial Performance

In 2024, Alpa Laboratories's revenue was 1.12 billion, an increase of 3.41% compared to the previous year's 1.09 billion. Earnings were 195.03 million, an increase of 16.25%.

Financial Statements

News

There is no news available yet.